Skip to content

The Finnish Faecal Microbiota Transplantation Study (FINFMT)

Long Term Safety and Efficacy of Faecal Microbiota Transplantation: a Nationwide Obeservational Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03732131
Acronym
FINFMT
Enrollment
200
Registered
2018-11-06
Start date
2018-10-18
Completion date
2029-01-15
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Faecal Microbiota Transplantation

Brief summary

The objective of the study is to follow up the long term effects of faecal microbiota tranplantation (FMT). All the over 18 years old patients receiving FMT and not included in other trials meet inclusion criteria to this study. Patients will be asked for a written consent. The outcome and possible side effects of the FMT will be followed by blood and feces samples for one year and with questionaires up to ten years after the FMT.

Interventions

None listed

Sponsors

University of Helsinki
CollaboratorOTHER
Helsinki University Central Hospital
CollaboratorOTHER
Turku University Hospital
CollaboratorOTHER_GOV
Tampere University Hospital
CollaboratorOTHER
Oulu University Hospital
CollaboratorOTHER
Kuopio University Hospital
CollaboratorOTHER
South Karelia, Social and Health Care District
CollaboratorOTHER
North Karelia Central Hospital
CollaboratorOTHER
Keski-Pohjanmaa Central Hospital
CollaboratorUNKNOWN
Seinajoki Central Hospital
CollaboratorOTHER
Jyväskylä Central Hospital
CollaboratorOTHER
Kanta-Häme Central Hospital
CollaboratorOTHER_GOV
Mikkeli Central Hospital
CollaboratorOTHER
Vaasa Central Hospital, Vaasa, Finland
CollaboratorOTHER
Lapland Central Hospital
CollaboratorUNKNOWN
Satakunta Central Hospital
CollaboratorOTHER
Kymenlaakso Social and Health Services
CollaboratorUNKNOWN
Kainuu Social and Health Care Joint Authority
CollaboratorOTHER
Joint Authority for Päijät-Häme Social and Health Care
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 120 Years
Healthy volunteers
No

Inclusion criteria

* \> 18 years age * receiving FMT for rCDI or any other madical condition * written consent * Not included in other FMT trials

Exclusion criteria

* Unable to provide written consent * \< 18 years age * Included in other FMT-trial

Design outcomes

Primary

MeasureTime frameDescription
The long term effects of FMT -questionnaire10 yearsThe questionnaire has 52 questions. Weight and height are asked and appearance of certain symptoms. The answers are mostly yes or no. The questionnaire is not validated and it is descriptive and the answers are not scored.

Countries

Finland

Contacts

Primary ContactPerttu Lahtinen, MD
perttu.lahtinen@phhyky.fi+358-3-819 11

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026